Biotech Medics has Acquired Organic Calcium Assets

WOODLAND HILLS, CA / ACCESSWIRE / October 2, 2023 / BioTech Medics, Inc. (OTC PINK:BMCS) is pleased to announce that the Company has acquired significant organic calcium carbonate assets and intends to begin supplying industry with calcium and produce a number of products to generate revenue. Our website can be found at www.biotechmedics.co

According to Anthony K. Miller, CEO, "As we previously reported, our business model going forward will be the biotech ecosystem will encompass calcium, calcium carbonate and related products. Last month management travelled to the Dominican Republic to meet and finalize an agreement in which the Company acquired 2 million metric tonnes of medical grade calcium carbonate: with an option on another 48 million tonnes in the future. This is a signific transaction for the Company, and the financial baseline value of this acquisition exceeds $30 million dollars. This asset will provide resources and revenue for the firm for the next 10-20 years. Note calcium is a significant commodity (worldwide demand is projected to exceed 19 million tonnes annually by 2030) that has far-reaching applications (see below). Over the next 3 months management will begin developing products for industry (like Amazon, Home Depot and other physical retail and on-line outlets) from our own mined assets. Over the next 15 months (our management and our calcium partners) project that BioTech Medics will produce at least $10 million dollars through marketing this product to industry (with projected profit margins of 25 to 50% of gross revenues). These projections were created based upon our partners own current operations. This projection is further projected to increase and expand year after year.

According to independent laboratory results, this medical grade asset has a 99.8% purity (with no metals) and thus provides us with the opportunity to market our products to a world-wide customer base. The Company along with our partners, over the next year, will procure processing equipment to refine this calcium to make a large variety of calcium carbonate and calcium dioxide products; that will be marketed. This is a transformative agreement, that management has made for the Company, and after completing our financial audits our goal is to upload to higher tiers on OTCM. We believe that our revenues, assets and share values will justify this elevation. In the coming weeks we will release press surrounding our actual shipped transactions commented Miller"